Suraj Kalia
Stock Analyst at Oppenheimer
(3.15)
# 1,223
Out of 5,090 analysts
85
Total ratings
47.22%
Success rate
12.95%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VREX Varex Imaging | Maintains: Outperform | $23 → $18 | $11.54 | +55.98% | 7 | Nov 19, 2025 | |
| EW Edwards Lifesciences | Downgrades: Perform | n/a | $86.26 | - | 6 | Oct 8, 2025 | |
| PRCT PROCEPT BioRobotics | Upgrades: Outperform | $60 | $35.86 | +67.32% | 2 | Sep 2, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $13.27 | +65.79% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $136.51 | +9.88% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $39.86 | +12.90% | 7 | Feb 13, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $177.43 | -32.37% | 6 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $44.63 | -28.30% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $84.16 | +10.50% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $125.08 | +3.93% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $10 | $7.05 | +41.84% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $4.84 | +168.60% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $69.87 | +93.23% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $256.55 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $27.91 | +7.49% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $1.15 | +17,291.30% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $85.46 | +13.50% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $25.44 | +10.08% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $3.06 | +47.06% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.23 | +1,200.81% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $575.34 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $1.92 | +34,275.00% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $136.81 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $3.62 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $18.53 | +439.67% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $65.49 | - | 5 | Sep 12, 2018 |
Varex Imaging
Nov 19, 2025
Maintains: Outperform
Price Target: $23 → $18
Current: $11.54
Upside: +55.98%
Edwards Lifesciences
Oct 8, 2025
Downgrades: Perform
Price Target: n/a
Current: $86.26
Upside: -
PROCEPT BioRobotics
Sep 2, 2025
Upgrades: Outperform
Price Target: $60
Current: $35.86
Upside: +67.32%
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $13.27
Upside: +65.79%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $136.51
Upside: +9.88%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $39.86
Upside: +12.90%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $177.43
Upside: -32.37%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $44.63
Upside: -28.30%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $84.16
Upside: +10.50%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $125.08
Upside: +3.93%
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $7.05
Upside: +41.84%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $4.84
Upside: +168.60%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $69.87
Upside: +93.23%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $256.55
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $27.91
Upside: +7.49%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $1.15
Upside: +17,291.30%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $85.46
Upside: +13.50%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $25.44
Upside: +10.08%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $3.06
Upside: +47.06%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.23
Upside: +1,200.81%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $575.34
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $1.92
Upside: +34,275.00%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $136.81
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $3.62
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $18.53
Upside: +439.67%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $65.49
Upside: -